Kevin Williams

The control of biologics microbiological impurities, contaminants, and mimetics is evolving.

The recognition that microbial artifacts are capable of modulating the mammalian immune system is an emerging view of biologic drug contamination control testing.

Low endotoxin recovery represents an opportunity to add value to the characterization of biologic drug products.